Dr. Shah on Indications of Early-Onset CRC

Video

In Partnership With:

Manish A. Shah, MD, director of gastrointestinal oncology, Weill Cornell Medicine/New York-Presbyterian Hospital, discusses indications of early-onset colorectal cancer (CRC).

Manish A. Shah, MD, director of gastrointestinal oncology, Weill Cornell Medicine/New York-Presbyterian Hospital, discusses indications of early-onset colorectal cancer (CRC).

Early-onset CRC is rising in incidence, which was confirmed on the most recent analysis, states Shah. SEER data, Risk Factor Analysis data, and available genomic data from The Cancer Genome Atlas (TCGA), were evaluated to determine if early-onset CRC is different to traditional CRC.

The results demonstrate that early-onset CRC is more prevalent in left-sided tumors. There is something specific about the biology of the left colon that is causing this increase, explains Shah.

Related Videos
Jeremy M. Pantin, MD, clinical director, Adult Transplant and Cellular Therapy Program, TriStar Centennial Medical Center, bone marrow transplant physician, Sarah Cannon Research Institute
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Akriti Jain, MD
Raj Singh, MD
Gottfried Konecny, MD
Karim Chamie, MD, associate professor, urology, the University of California, Los Angeles
Mike Lattanzi, MD, medical oncologist, Texas Oncology
Ramez N. Eskander, MD
Elias Jabbour, MD
Shruti Tiwari, MD